{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T20:05:53Z","timestamp":1720382753108},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.leukres.2018.12.008","type":"journal-article","created":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T09:17:55Z","timestamp":1545470275000},"page":"5-7","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Prognostic significance of lymphocyte\/monocyte count and neutrophil\/lymphocyte count in peripheral T cell lymphoma"],"prefix":"10.1016","volume":"77","author":[{"given":"Emanuele","family":"Cencini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sicuranza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Bocchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2018.12.008_bib0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.leukres.2018.07.020","article-title":"A lower ALC\/AMC ratio is associated with poor prognosis of peripheral T-cell lymphoma-not otherwise specified","volume":"73","author":"Li","year":"2018","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2018.12.008_bib0010","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2018.12.008_bib0015","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.12.008_bib0020","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3109\/10428194.2011.573031","article-title":"Lenalidomide monotherapy for relapsed\/refractory peripheral T-cell lymphoma not otherwise specified","volume":"52","author":"Zinzani","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2018.12.008_bib0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/hon.2038","article-title":"Impressive activity of lenalidomide monotherapy in refractory angioimmunoblastic T-cell lymphoma: report of a case with long-term follow-up","volume":"31","author":"Fabbri","year":"2013","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.leukres.2018.12.008_bib0030","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2017-05-780049","article-title":"Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma","volume":"130","author":"Pro","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.12.008_bib0035","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3324\/haematol.2017.186577","article-title":"The outcome of peripheral T-cell lymphoma patients failing first line therapy: a report from the prospective, international T-Cell project","volume":"103","author":"Bellei","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2018.12.008_bib0040","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.12.008_bib0045","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00277-018-3276-y","article-title":"Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy","volume":"97","author":"Romano","year":"2018","journal-title":"Ann. Haematol."},{"key":"10.1016\/j.leukres.2018.12.008_bib0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/10428194.2015.1045897","article-title":"The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified","volume":"57","author":"Beltran","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2018.12.008_bib0055","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.15141","article-title":"The neutrophil-lymphocyte ratio is prognostic in patients with early stage aggressive peripheral T cell lymphoma","author":"Beltran","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"181","key":"10.1016\/j.leukres.2018.12.008_bib0060","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/bjh.15258","article-title":"Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network","author":"Federico","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2018.12.008_bib0065","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.leukres.2018.12.008_bib0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/hon.2249","article-title":"Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment","volume":"35","author":"Cencini","year":"2017","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.leukres.2018.12.008_bib0075","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.18632\/oncotarget.14289","article-title":"Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618305010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618305010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T01:22:39Z","timestamp":1605748959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212618305010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":15,"alternative-id":["S0145212618305010"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2018.12.008","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic significance of lymphocyte\/monocyte count and neutrophil\/lymphocyte count in peripheral T cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2018.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}